(S,R)-3-Phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent

Details for Australian Patent Application No. 2008250676 (hide)

Owner Ganial Immunoterapeutics Inc.

Inventors Nicoletti, Ferninando; Al-Abed, Yousef; Garotta, Gianni

Agent Spruson & Ferguson

Pub. Number AU-A-2008250676

PCT Pub. Number WO2008/138516

Priority 60/924,321 09.05.07 US

Filing date 6 May 2008

Wipo publication date 20 November 2008

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/42 (2006.01) - Oxazoles

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 November 2009 PCT application entered the National Phase

  PCT publication WO2008/138516 Priority application(s): WO2008/138516

19 January 2012 Assignment before Grant

  Ganial Immunoterapeutics Inc. The application has been assigned to OncoNOx ApS

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008250690-Storage cart for bulk material

2008250673-Container having CO2 compressed gas source and overpressure burst safeguard